Literature DB >> 23526651

Structural characterization of pharmaceutical heparins prepared from different animal tissues.

Li Fu1, Guoyun Li, Bo Yang, Akihiro Onishi, Lingyun Li, Peilong Sun, Fuming Zhang, Robert J Linhardt.   

Abstract

Although most pharmaceutical heparin used today is obtained from porcine intestine, heparin has historically been prepared from bovine lung and ovine intestine. There is some regulatory concern about establishing the species origin of heparin. This concern began with the outbreak of mad cow disease in the 1990s and was exacerbated during the heparin shortage in the 2000s and the heparin contamination crisis of 2007-2008. Three heparins from porcine, ovine, and bovine were characterized through state-of-the-art carbohydrate analysis methods with a view profiling their physicochemical properties. Differences in molecular weight, monosaccharide and disaccharide composition, oligosaccharide sequence, and antithrombin III-binding affinity were observed. These data provide some insight into the variability of heparins obtained from these three species and suggest some analytical approaches that may be useful in confirming the species origin of a heparin active pharmaceutical ingredient.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23526651      PMCID: PMC3866627          DOI: 10.1002/jps.23501

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  19 in total

1.  Determination of molecular weight of heparin by size exclusion chromatography with universal calibration.

Authors:  X Guo; M Condra; K Kimura; G Berth; H Dautzenberg; P L Dubin
Journal:  Anal Biochem       Date:  2003-01-01       Impact factor: 3.365

2.  Purification and characterization of heparin from the Italian clam Callista chione.

Authors:  Elisa Luppi; Marina Cesaretti; Nicola Volpi
Journal:  Biomacromolecules       Date:  2005 May-Jun       Impact factor: 6.988

3.  Mapping and quantification of the major oligosaccharide components of heparin.

Authors:  R J Linhardt; K G Rice; Y S Kim; D L Lohse; H M Wang; D Loganathan
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

Review 4.  New variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy.

Authors:  L B Schonberger
Journal:  Infect Dis Clin North Am       Date:  1998-03       Impact factor: 5.982

5.  Structural variation in the antithrombin III binding site region and its occurrence in heparin from different sources.

Authors:  D Loganathan; H M Wang; L M Mallis; R J Linhardt
Journal:  Biochemistry       Date:  1990-05-08       Impact factor: 3.162

6.  Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures.

Authors:  Jinghua Chen; Courtney L Jones; Jian Liu
Journal:  Chem Biol       Date:  2007-09

7.  Top-down approach for the direct characterization of low molecular weight heparins using LC-FT-MS.

Authors:  Lingyun Li; Fuming Zhang; Joseph Zaia; Robert J Linhardt
Journal:  Anal Chem       Date:  2012-09-26       Impact factor: 6.986

8.  Isolation and characterization of human heparin.

Authors:  R J Linhardt; S A Ampofo; J Fareed; D Hoppensteadt; J B Mulliken; J Folkman
Journal:  Biochemistry       Date:  1992-12-15       Impact factor: 3.162

9.  Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.

Authors:  U Lindahl; G Bäckström; L Thunberg; I G Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

10.  Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.

Authors:  P Hovingh; M Piepkorn; A Linker
Journal:  Biochem J       Date:  1986-07-15       Impact factor: 3.857

View more
  34 in total

1.  Analysis of 3-O-sulfo group-containing heparin tetrasaccharides in heparin by liquid chromatography-mass spectrometry.

Authors:  Guoyun Li; Bo Yang; Lingyun Li; Fuming Zhang; Changhu Xue; Robert J Linhardt
Journal:  Anal Biochem       Date:  2014-03-28       Impact factor: 3.365

2.  Keratan sulfate glycosaminoglycan from chicken egg white.

Authors:  Li Fu; Xiaojun Sun; Wenqin He; Chao Cai; Akihiro Onishi; Fuming Zhang; Robert J Linhardt; Zhangguo Liu
Journal:  Glycobiology       Date:  2016-02-21       Impact factor: 4.313

3.  Combinatorial one-pot chemoenzymatic synthesis of heparin.

Authors:  Ujjwal Bhaskar; Guoyun Li; Li Fu; Akihiro Onishi; Mathew Suflita; Jonathan S Dordick; Robert J Linhardt
Journal:  Carbohydr Polym       Date:  2014-11-07       Impact factor: 9.381

4.  Structure and activity of a new low-molecular-weight heparin produced by enzymatic ultrafiltration.

Authors:  Li Fu; Fuming Zhang; Guoyun Li; Akihiro Onishi; Ujjwal Bhaskar; Peilong Sun; Robert J Linhardt
Journal:  J Pharm Sci       Date:  2014-03-14       Impact factor: 3.534

5.  A purification process for heparin and precursor polysaccharides using the pH responsive behavior of chitosan.

Authors:  Ujjwal Bhaskar; Anne M Hickey; Guoyun Li; Ruchir V Mundra; Fuming Zhang; Li Fu; Chao Cai; Zhimin Ou; Jonathan S Dordick; Robert J Linhardt
Journal:  Biotechnol Prog       Date:  2015-07-16

Review 6.  Advances in the preparation and synthesis of heparin and related products.

Authors:  Sultan N Baytas; Robert J Linhardt
Journal:  Drug Discov Today       Date:  2020-09-16       Impact factor: 7.851

7.  Stable isotopic analysis of porcine, bovine, and ovine heparins.

Authors:  John P Jasper; Fuming Zhang; Russell B Poe; Robert J Linhardt
Journal:  J Pharm Sci       Date:  2014-09-03       Impact factor: 3.534

8.  Immobilized enzymes to convert N-sulfo, N-acetyl heparosan to a critical intermediate in the production of bioengineered heparin.

Authors:  Jian Xiong; Ujjwal Bhaskar; Guoyun Li; Li Fu; Lingyun Li; Fuming Zhang; Jonathan S Dordick; Robert J Linhardt
Journal:  J Biotechnol       Date:  2013-07-05       Impact factor: 3.307

9.  Bioengineering murine mastocytoma cells to produce anticoagulant heparin.

Authors:  Leyla Gasimli; Charles A Glass; Payel Datta; Bo Yang; Guoyun Li; Trent R Gemmill; Jong Youn Baik; Susan T Sharfstein; Jeffrey D Esko; Robert J Linhardt
Journal:  Glycobiology       Date:  2013-12-09       Impact factor: 4.313

Review 10.  Heparin and related polysaccharides: synthesis using recombinant enzymes and metabolic engineering.

Authors:  Matthew Suflita; Li Fu; Wenqin He; Mattheos Koffas; Robert J Linhardt
Journal:  Appl Microbiol Biotechnol       Date:  2015-07-29       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.